2024 연구자 정보 (21 / 1073)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Terashima, Masanori
(Terashima, M)
Shizuoka Canc Ctr, Div Gastr Surg, Shizuoka, Japan

[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial SCIE 1.0 GASTROENTEROLOGY & HEPATOLOGY msasako2010@yahoo.co.jp
Thanawala, Vaidehi
(Thanawala, V)
Vir Biotechnol, San Francisco, CA USA

[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study SCIE 1.0 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hkucc.hku.hk
Woo, Yu Mi
(Woo, YM)
Kumoh Natl Inst Technol, Dept Mech Engn, Dept Aeronaut Mech & Elect Convergence Engn, 61 Daehak Ro, Gumi 39177, Gyeongbuk, South Korea

[JCR상위 1.0%] Light-Material Interactions Using Laser and Flash Sources for Energy Conversion and Storage Applications SCIE 1.0 MATERIALS SCIENCE, MULTIDISCIPLINARY
NANOSCIENCE & NANOTECHNOLOGY
PHYSICS, APPLIED
kipark@knu.ac.kr
keonlee@kaist.ac.kr
jhryu@ynu.ac.kr
Yamada, Takanobu
(Yamada, T)
Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Japan

[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial SCIE 1.0 GASTROENTEROLOGY & HEPATOLOGY msasako2010@yahoo.co.jp
Yeh, Ta-Sen
(Yeh, TS)
Chang Gung Univ, Linkou Chang Gung Mem Hosp, Dept Surg, Taoyuan, Taiwan

[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial SCIE 1.0 GASTROENTEROLOGY & HEPATOLOGY msasako2010@yahoo.co.jp
Yoon, G.
(Yoon, G)
Natl Inst Math Sci, Daejeon 34047, South Korea

[JCR상위 1.0%] THE IMPORTANCE OF PROVEN TREATMENT AS A VACCINE MODEL FOR COVID-19 SCIE 1.0 MATHEMATICS, APPLIED sangil.kim@pusan.ac.kr
Yuen, Man-Fung
(Yuen, MF)
제1저자 교신저자 Univ Hong Kong, Sch Clin Med, Dept Med, Hong Kong, Peoples R China
Univ Hong Kong, Dept Microbiol, Hong Kong, Special Adm Reg, Peoples R China
C-4466-2009
Yuen, Richard Man Fung

[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study SCIE 1.0 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hkucc.hku.hk
Zhang, Tiandong
(Zhang, TD)
Harbin Univ Sci & Technol, Sch Elect & Elect Engn, Harbin 150080, Peoples R China
Harbin Univ Sci & Technol, Key Lab Engn Dielect & Its Applicat, Minist Educ, Harbin 150080, Peoples R China


[JCR상위 1.0%] Light-Material Interactions Using Laser and Flash Sources for Energy Conversion and Storage Applications SCIE 1.0 MATERIALS SCIENCE, MULTIDISCIPLINARY
NANOSCIENCE & NANOTECHNOLOGY
PHYSICS, APPLIED
kipark@knu.ac.kr
keonlee@kaist.ac.kr
jhryu@ynu.ac.kr
Aguilar, C. Orbegoso
(Aguilar, CO)
Daiichi Sankyo Inc, Dept Global Oncol R&D, Rueil Malmaison, France

[JCR상위 1.1%] Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician's choice in HER2-low, hormone receptorepositive metastatic breast cancer in DESTINY-Breast04 SCIE 1.1 ONCOLOGY
Al-Ahmadie, H.
(Al-Ahmadie, H)
Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, New York, NY USA

[JCR상위 1.1%] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) SCIE 1.1 ONCOLOGY
Alam, Md Badrul
(Alam, MB)
Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu 41566, South Korea
Kyungpook Natl Univ, Food & Bioind Res Inst, Inner Beauty Antiaging Ctr, Daegu 41566, South Korea
Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu, South Korea
Kyungpook Natl Univ, Food & Bioind Res Inst, Inner Beauty Antiaging Ctr, Daegu, South Korea
AFL-7668-2022
Alam, Md Badrul
0000-0002-8509-6827
ALAM, MD BADRUL
[JCR상위 1.1%] γ-Mangosteen, an autophagy enhancer, prevents skin-aging via activating KEAP1/NRF2 signaling and downregulating MAPKs/AP-1/ NF-κB-mediated MMPs
[JCR상위 5.9%] Glycoprotein from Sargassum fusiforme exhibiting anti-inflammatory responses in vitro and in vivo via modulation of TLR4/MyD88 and NF-κB signaling
[JCR상위 33.2%] Biological activities, identification, method development, and validation for analysis of polyphenolic compounds in Nymphaea rubra flowers and leaves by UHPLC-Q-cIM-TOF-MS and UHPLC-TQ-MS
[JCR상위 10.4%] RSM- and ANN-Based Multifrequency Ultrasonic Extraction of Polyphenol-Rich Sargassum horneri Extracts Exerting Antioxidative Activity via the Regulation of MAPK/Nrf2/HO-1 Machinery
[JCR상위 10.3%] Development of a rapid screening method utilizing 2D LC for effect-directed analysis in the identification of environmental toxicants
[JCR상위 10.4%] Optimization, Metabolomic Analysis, Antioxidant Potential and Depigmenting Activity of Polyphenolic Compounds from Unmature Ajwa Date Seeds (Phoenix dactylifera L.) Using Ultrasonic-Assisted Extraction
[JCR상위 10.7%] Glutamic-Alanine Rich Glycoprotein from Undaria pinnatifida: A Promising Natural Anti-Inflammatory Agent
SCIE 1.1 CHEMISTRY, MEDICINAL
INTEGRATIVE & COMPLEMENTARY MEDICINE
PHARMACOLOGY & PHARMACY
PLANT SCIENCES
BIOCHEMISTRY & MOLECULAR BIOLOGY
CHEMISTRY, APPLIED
POLYMER SCIENCE
BIOCHEMICAL RESEARCH METHODS
CHEMISTRY, ANALYTICAL
FOOD SCIENCE & TECHNOLOGY
ENVIRONMENTAL SCIENCES
sang@knu.ac.kr
sunghwank@knu.ac.kr
ahsanjaved@knu.ac.kr
mbalam@knu.ac.kr
naznin@knu.ac.kr
ahmed@knu.ac.kr
changhyung@snu.ac.kr
alfnar744@gmail.com
md-saifur.rahman.1@ulaval.ca
mosammad-hur.madina.1@ulaval.ca
rafiquzzaman@bsmrau.edu.bd
Antonuzzo, L.
(Antonuzzo, L)
Univ Careggi, Azienda Osped, SODc Oncol Med, Florence, Italy

[JCR상위 1.1%] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) SCIE 1.1 ONCOLOGY
Armstrong, J.
(Armstrong, J)
AstraZeneca, Stat, Cambridge, England

[JCR상위 1.1%] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) SCIE 1.1 ONCOLOGY
Atduev, V.
(Atduev, V)
Fed Med Biol Agcy, Volga Dist Med Ctr, Nizhnii Novgorod, Russia

[JCR상위 1.1%] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) SCIE 1.1 ONCOLOGY
Ba, Y.
(Ba, Y)
TMUCIH Tianjin Med Univ Canc Inst & Hosp, Dept GI Med Oncol, Tianjin, Peoples R China

[JCR상위 1.1%] Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+aGC/GEJC) in East Asia (HER2+GASTA) SCIE 1.1 ONCOLOGY
페이지 이동: